High Specificity in Circulating Tumor Cell Identification Is Required for Accurate Evaluation of Programmed Death-Ligand 1
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High Specificity in Circulating Tumor Cell Identification Is Required for Accurate Evaluation of Programmed Death-Ligand 1
Authors
Keywords
-
Journal
PLoS One
Volume 11, Issue 7, Pages e0159397
Publisher
Public Library of Science (PLoS)
Online
2016-07-27
DOI
10.1371/journal.pone.0159397
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tools for Single-Cell Kinetic Analysis of Virus-Host Interactions
- (2016) Jay W. Warrick et al. PLoS One
- Up-regulation of Programmed Cell Death 1 Ligand 1 on Neutrophils May Be Involved in Sepsis-induced Immunosuppression
- (2015) Jia-Feng Wang et al. ANESTHESIOLOGY
- High-resolution imaging for the detection and characterisation of circulating tumour cells from patients with oesophageal, hepatocellular, thyroid and ovarian cancers
- (2015) Barry M. Dent et al. INTERNATIONAL JOURNAL OF CANCER
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
- (2015) Julie Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2015) Hossein Borghaei et al. NEW ENGLAND JOURNAL OF MEDICINE
- RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance
- (2015) D. T. Miyamoto et al. SCIENCE
- Circulating tumor-associated neutrophils (cTAN) contribute to circulating tumor cell survival by suppressing peripheral leukocyte activation
- (2015) Juechao Zhang et al. TUMOR BIOLOGY
- The detection of EpCAM+ and EpCAM– circulating tumor cells
- (2015) Sanne de Wit et al. Scientific Reports
- An Introduction to Automated Flow Cytometry Gating Tools and Their Implementation
- (2015) Chris P. Verschoor et al. Frontiers in Immunology
- EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer
- (2015) Helen Schneck et al. PLoS One
- Efficient Sample Preparation from Complex Biological Samples Using a Sliding Lid for Immobilized Droplet Extractions
- (2014) Benjamin P. Casavant et al. ANALYTICAL CHEMISTRY
- Universal Marker and Detection Tool for Human Sarcoma Circulating Tumor Cells
- (2014) Arun Satelli et al. CANCER RESEARCH
- Microfluidic, marker-free isolation of circulating tumor cells from blood samples
- (2014) Nezihi Murat Karabacak et al. Nature Protocols
- Paired diagnostic and pharmacodynamic analysis of rare non-small cell lung cancer cells enabled by the VerIFAST platform
- (2013) Benjamin P. Casavant et al. LAB ON A CHIP
- Technologies for detection of circulating tumor cells: facts and vision
- (2013) Catherine Alix-Panabières et al. LAB ON A CHIP
- Inertial Focusing for Tumor Antigen-Dependent and -Independent Sorting of Rare Circulating Tumor Cells
- (2013) E. Ozkumur et al. Science Translational Medicine
- Changes in Keratin Expression during Metastatic Progression of Breast Cancer: Impact on the Detection of Circulating Tumor Cells
- (2012) S. A. Joosse et al. CLINICAL CANCER RESEARCH
- Circulating Tumors Cells as Biomarkers
- (2011) Daniel C. Danila et al. CANCER JOURNAL
- Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non–Small-Cell Lung Cancer
- (2011) Matthew G. Krebs et al. JOURNAL OF CLINICAL ONCOLOGY
- Analysis of Circulating Tumor Cells in Patients with Non-small Cell Lung Cancer Using Epithelial Marker-Dependent and -Independent Approaches
- (2011) Matthew G. Krebs et al. Journal of Thoracic Oncology
- Detection of EpCAM-Negative and Cytokeratin-Negative Circulating Tumor Cells in Peripheral Blood
- (2011) Stephen D. Mikolajczyk et al. Journal of Oncology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation